AMAR

Members of the Exchange are hereby notified that in terms of Regulations of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Securities Contract (Regulations) Rules, 1957 and Bye-Laws of the Exchange, it has been decided to delist (withdraw the admission to dealings in) equity shares of Amar Remedies Limited (AMAR) w.e.f. October 17, 2019 as per SEBI (Delisting of Equity Shares) Regulations, 2009.

Members of the Exchange are hereby informed that the Exchange on June 06,2019 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/Corporate Announcements).

Members of the Exchange are hereby informed that the Exchange on February 02, 2018 has issued public notice in the newspaper for�� proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements).

Members of the Exchange are hereby informed that trading in the equity shares of Amar Remedies Limited will be suspended w.e.f. December 10, 2013 (i.e. closing hours of trading on December 09, 2013) as the company has failed to respond satisfactorily to the notices of the Exchange for non-compliance with the provisions of listing agreement.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30,2013.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended March 31,2013.

Amar Remedies Limited has informed the Exchange that the Company's Non-Executive Director- Mr. Yusuf Iqbal Yusuf has resigned from the post of Director of the company w.e.f. February 04, 2013.

Amar Remedies Limited has informed the Exchange that the Company's Non-Executive Director - Mrs. Preeti A. Patel has resigned from the post of Director of the Company w.e.f. March 09, 2013.

Amar Remedies Limited has informed the Exchange that the Company's Non-Executive Director - Mr. Jyotirmay P. Varma has resigned from the post of Director of the Company w.e.f. March 11, 2013.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2012.

Amar Remedies Limited has informed the Exchange that Mr. Rajiv M. Chitnis has resigned w.e.f. January 15, 2013 as Executive Director and Compliance Officer of the Company.

Amar Remedies Limited has informed the Exchange regarding the Outcome of Annual General Meeting of the Members of the Company held on December 26, 2012.

Amar Remedies Limited has informed the Exchange that Mr. Jagdish Nagpal has resigned from the post a Company Secretary w.e.f. December 08, 2012.

Amar Remedies Limited has informed the Exchange that the Board of Directors in its meeting held on November 28, 2012, transacted the following business: a) To convene the Annual General Meeting of the Company for the year ended June 30, 2012 on December 26, 2012; (b) To close the Register of Members from December 19, 2012 to December 26, 2012 for the purpose of Annual General Meeting.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30,2012.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2012.

Sagar P. Shah has submitted to the Exchange, vide letter dated July 04, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange, vide letter dated June 26, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange, vide letter dated June 18, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange vide its letter dated June 06, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange vide its letter dated May 29, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange vide its letter dated May 21, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2012.

Sagar P. Shah has submitted to the Exchange vide its letter dated May 11, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange vide its letter dated May 04, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange vide its letter dated April 03, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Amar Remedies Limited has informed the Exchange, vide letter dated March 28, 2012 regarding the 'Declaration of Results of Postal Ballot".

Amar Remedies Limited has submitted to the Exchange, vide letter dated March 21, 2012 a copy of Notice of Postal Ballot.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results along with limited Review Report for the period ended December 31,2011.

Amar Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 09, 2012, has accorded their approval to the following items : (1) To raise an additional funds by way of issue of Securities including equity shares and/or equity linked securities and/ or Compulsory Convertible Debentures and/or GDR and/or ADR and/or Non-Convertible Debentures with Detachable Warrants through any permissible route including through a Qualified Institutions Placement upto US $ 90 million (US $ Ninety Million only) in supersession of the earlier shareholde

Sagar P. Shah has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sagar P. Shah has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Amar Remedies Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.

Amar Remedies Limited has informed the Exchange that Mr. Ashwin N. Panditpautra has resigned from the post of the company secretary w.e.f. September 01, 2011 and Mr. Jagdish Nagpal has been appointed as Company Secretary w.e.f. September 01, 2011.

Amar Remedies Limited has submitted to the Exchange a certified true copy of resolution passed by the Board of Directors of the Company at their meeting held on October 06, 2011 for application to the Foreign Investment Promotion Board for the participation of FIIs in the QIP.

Amar Remedies Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the Members of the Company held on September 30, 2011.

Amar Remedies Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended June 30,2011.

Amar Remedies Limited has informed the Exchange that the Board of Directors in its meeting held on August 26, 2011, transacted the following business: a) To convene the Annual General Meeting of the Company for the year ended June 30, 2011 on September 30, 2011; (b) To close the Register of Members from September 23, 2011 to September 30, 2011 for the purpose of Annual General Meeting and Dividend.

Amar Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 26, 2011 has transacted the following business : (1) To issue Non-Convertible Debentures (NCDs) with detachable Convertible Warrants upto Rs.200.00 Cr. (Rupees Two Hundred Crores Only).

Amar Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 26, 2011 has recommended dividend @ 10% (Rs.1 per share) on fully paid Equity Shares of Rs.10/- each of the company for the financial year ended June 30, 2011.The dividend warrants will be despatched on October 25, 2011.

Amar Remedies Limited has informed the Exchange that the Board of Directors at its meeting held on July 12, 2011, re-appointed Mr. Rajiv M. Chitnis as Whole time Director designated as Executive Director of the Company, subject to members approval, for the period of 3 years w.e.f. July 09, 2011.

Amar Remedies Limited has informed the Exchange vide its letter dated June 15, 2011 regarding Declaration of Results of Postal Ballot.

Amar Remedies Limited has submitted to the Exchange a copy of Notice pursuant to section 192A of the Companies Act, 1956, read with the Companies (Passing of Resolution by Postal Ballot) Rules 2001, in respect of resolution to be passed by Postal Ballot: (1) Special Resolution for Issue of GDR/FCCB/QIP/NCD/CCD/ &/or Issue of Shares/Share Warrants/Debentures to the Qualified Institutional Buyers (QIB). (2) Ordinary Resolution for Sale of Factory Land and Building of the Company situated at Surat (3) Ordinary Resolution for sale of Factory Land and Building of the Company situated at Dehradun.

Amar Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 06, 2011 have approved the following: (1) To raise an additional funds by way of issue of GDR/FCCB/QIP/NCD/CCD and issue of Shares/ Share Warrants/Debentures to the Qualified Institutional Buyers (QIB) upto $60 million ($ Sixty million only) (2) To sell excess and unutilized factory Land and Building as a part of Strategic Planning. The Board of Directors has decided to obtain shareholders' approval for the above mentioned points through Postal Ballot.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2011.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2010.

Amar Remedies Limited has submitted to the Exchange a copy of Disclosure of pledge shares as per Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) (Amendment) Regulations, 2009.

Amar Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2010.